Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535430 · ClinicalTrials.gov registry record
Assessment of Eloquent Function in Brain Tumor Patients
A clinical trial of Primary Brain Tumor and Metastatic Brain Tumor, sponsored by University of Nebraska.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT01535430: Recruiting study of Primary Brain Tumor and Metastatic Brain Tumor, sponsored by University of Nebraska.
NCT01535430 is a study of Primary Brain Tumor and Metastatic Brain Tumor that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 75 participants, roughly in line with the 75-participant average among 7 other Primary Brain Tumor trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01535430, a study of Primary Brain Tumor and Metastatic Brain Tumor, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose of the study: AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the location of eloquent brain function. In addition, each modality will be compared with the other. AIM 2: Assess reorganization of eloquent brain function and plasticity in patients with intra-axial brain tumors. This will be accomplished by prospectively collecting post-operative mapping studies and neuropsychological tests to compare them to prior mapping studies as stated above.
Primary Outcome
The location of the eloquent function of interest (motor, sensory, speech) will be assessed pre-operatively and intra-operatively and compared. Then, at 2 and 6 months post-operatively, repeat non-invasive mapping studies will be performed to compare to the subjects' prior studies. This will allow for assessment of reorganization and plasticity of function. Additionally, novel ways of identifying eloquent brain regions will be developed.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Brain mapping
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-01-31 |
| Est. Completion | 2027-12 |
What NCT01535430 shows while recruiting
NCT01535430 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, roughly in line with the 75-participant average among 7 other Primary Brain Tumor trials with a reported enrollment target.
The record links to 2 conditions, with Primary Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Brain mapping is the first listed.
NCT01535430 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT01535430 about?
NCT01535430 is a clinical study titled "Assessment of Eloquent Function in Brain Tumor Patients". Purpose of the study: AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the lo...
What is the current status of trial NCT01535430?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2012-01-31. Estimated completion is 2027-12.
What conditions does trial NCT01535430 study?
This clinical trial studies the following conditions: Primary Brain Tumor, Metastatic Brain Tumor.
What interventions are being tested in trial NCT01535430?
The interventions under investigation include: Brain mapping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01535430?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01535430 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
RECRUITING
-
Non-invasive Glioma Characterization Through Molecular Imaging
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
RECRUITING · Phase 1
-
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
ACTIVE NOT RECRUITING · Early Phase 1
-
Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
- NCT03128034 · 75 participants · Phase 1
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI